You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Participant pharmacists’ attitudes on generic medicine in Palestine (n = 302)

From: Knowledge, attitudes and practices of community pharmacists on generic medicines in Palestine: a cross-sectional study

Attitudinal item Strongly agree N (%) Agree N (%) Neutral N (%) Disagree N (%) Strongly disagree N (%)
1. I support generic substitution for brand name drugs in all cases where a generic is available. 66 (21.9) 122 (40.4) 17 (5.6) 85(28.1) 12 (4.0)
2. Wider use of generic medicines will mean that less money will be spent for research and development of new pharmaceuticals. 38 (12.6) 130(43.0) 58 (19.2) 69(22.8) 7 (2.3)
3. Wider use of generic medicines will result in decrease in health care expenditure by the government of Palestine. 51 (16.9) 155 (51.3) 46 (15.2) 43(14.2) 7 (2.3)
4. Switching a patient from branded medicine to a generic medicine may change the outcome of the drug therapy. 16 (5.3) 75 (24.8) 54 (17.9) 132(43.7) 25 (8.3)
5. Therapeutic failure is a serious problem with most generic products. 13 (4.3) 27 (8.9) 35 (11.6) 176(58.3) 51 (16.9)
6. All products approved as generic drugs by the health authorities in the state of Palestine can be considered therapeutically equivalent to their branded counterparts. 48 (15.9) 171 (56.6) 35 (11.6) 42(13.9) 6 (2.0)
7. The price difference between generic and branded drugs is often so great that I feel I must dispense prescriptions with generic substitution, especially for people who do not have prescription drug benefits in Palestine. 57 (18.9) 147 (48.7) 18 (6.0) 68(22.5) 12 (4.0)
8. Patients should be given enough explanations about the reasons for choosing generic medicines for them. 75 (24.8) 171 (56.6) 17 (5.6) 31(10.3) 8 (2.6)
9. Community pharmacists in Palestine should be given generic substitution right. 117 (38.7) 147 (48.7) 16 (5.3) 17 (5.6) 5 (1.7)
10. The intensity of promotional activities by medical representatives plays an important role in dispensing generics. 99 (32.8) 174 (57.6) 9 (3.0) 16 (5.3) 4 (1.3)
11. Health authorities in Palestine should implement policies such that bioequivalence data are mandatory before a generic product is marketed. 135 (44.7) 153 (50.7) 7 (2.3) 6 (2.0) 1 (0.3)
12. Community pharmacists should be allowed to perform generic substitution without consulting the prescribing physician. 91 (30.1) 119 (39.4) 30 (9.9) 49(16.2) 13(4.3)
13. Community pharmacists must consult the prescribing physician when performing generic substitution. 23 (7.6) 97 (32.1) 34 (11.3) 121(40.1) 27 (8.9)
14. Community pharmacists should only be required to consult the prescribing physician when substituting certain categories of drugs, such as those with narrow therapeutic index. 65 (21.5) 130 (43.0) 39 (12.9) 62(20.5) 6 (2.0)
15. In general, I would not dispense generic medicine to my patients. 19 (6.3) 67 (22.2) 44 (14.6) 122(40.4) 50 (16.6)